about
Utilization of a ts-sacB selection system for the generation of a Mycobacterium avium serovar-8 specific glycopeptidolipid allelic exchange mutantSystemic causes of cholestasisManagement of cerebral infection.Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophagesIn vivo activities of newer rifamycin analogs against Mycobacterium avium infectionActivities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophagesEffect of rifabutin on disseminated Mycobacterium avium infections in thymectomized, CD4 T-cell-deficient miceLiposome-encapsulated-gentamicin therapy of Mycobacterium avium complex infection in beige miceGeneration of monoclonal antibodies to the specific sugar epitopes of Mycobacterium avium complex serovarsComparative antimycobacterial activities of difloxacin, temafloxacin, enoxacin, pefloxacin, reference fluoroquinolones, and a new macrolide, clarithromycinIn vitro and in vivo activities of clarithromycin against Mycobacterium aviumTherapeutic efficacy of liposomal rifabutin in a Mycobacterium avium model of infectionAmikacin, ciprofloxacin, and imipenem treatment for disseminated Mycobacterium avium complex infection of beige miceClarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige miceIn vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859aActivities of rifabutin, clarithromycin, and ethambutol against two virulent strains of Mycobacterium avium in a mouse modelA bone marrow-derived murine macrophage model for evaluating efficacy of antimycobacterial drugs under relevant physiological conditionsActivity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infectionAzithromycin, rifabutin, and rifapentine for treatment and prophylaxis of Mycobacterium avium complex in rats treated with cyclosporineFormulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infectionActivity of KRM-1648 alone or in combination with both ethambutol and kanamycin or clarithromycin against Mycobacterium intracellulare infections in beige miceRationale for and efficacy of prolonged-interval treatment using liposome-encapsulated amikacin in experimental Mycobacterium avium infection.Low-dose dexamethasone as adjunctive therapy for disseminated Mycobacterium avium complex infections in AIDS patientsInvasion of the brain and chronic central nervous system infection after systemic Mycobacterium avium complex infection in mice.Disparate responses to oxidative stress in saprophytic and pathogenic mycobacteria.Inhibition of growth of Mycobacterium avium in murine and human mononuclear phagocytes by migration inhibitory factorProduction and characterization of monoclonal antibodies against specific serotypes of Mycobacterium avium and the Mycobacterium avium-Mycobacterium intracellulare-Mycobacterium scrofulaceum complexBinding of Mycobacterium avium-Mycobacterium intracellulare to human leukocytes.Therapeutic efficacy of liposomal clofazimine against Mycobacterium avium complex in mice depends on size of initial inoculum and duration of infection.Epidemiology of infection by nontuberculous mycobacteriaResponse to stimulation with recombinant cytokines and synthesis of cytokines by murine intestinal macrophages infected with the Mycobacterium avium complexIntracellular fate of Mycobacterium avium: use of dual-label spectrofluorometry to investigate the influence of bacterial viability and opsonization on phagosomal pH and phagosome-lysosome interactionMycobacterium avium complex and Mycobacterium tuberculosis in patients infected with the human immunodeficiency virusTemporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium aviumAn unusual case of post-operative spondylitis caused by mycobacterium intracellulare in an immunosuppressed patientCytokine secretion and adhesion molecule expression by granuloma T lymphocytes in Mycobacterium avium infectionBacterial challenges and evolving antibacterial drug strategy.Immunosuppression and mycobacteria other than Mycobacterium tuberculosis: results from patients with and without HIV infectionClinical implications of positive blood cultures.The Mycobacterium avium complex
P2860
Q24803824-C5372D01-57F2-4A08-A368-D041678AE8EBQ27008041-4E6DCC61-65EF-497D-ACCC-B8EAB55A160DQ27469303-97E3BD14-5CDC-41E6-998F-77E244C0464BQ28321761-0494D302-F4C2-4230-84E5-84A68F4ACED2Q28322002-6080CDD5-A558-49B8-B878-ACE0EC90A835Q28330701-A363932C-3105-4E57-9C6C-7B546DDB325DQ28330848-28026C3C-AC83-4E9F-B820-A54F00D6E5A2Q28335928-7D22C7A2-22DB-40C3-8DF2-9DA7ADBA54F0Q28340159-272A3CE4-BBE6-4770-BFB6-B8DF5C243D76Q28341927-14BCF37C-92C5-4E8F-A663-4C15AB811A26Q28342095-AD0BE052-D682-4310-A49E-F7E94301D95BQ28344603-25935766-6307-4BEF-9BB9-FD7280FEA958Q28356424-661F69B4-E742-4CB8-838B-C488BD0CA35CQ28368056-5DFA00BF-1073-463D-A9E7-1E40EA5CD9BFQ28368060-769D32F1-F13F-4F9A-BD85-195B49820320Q28368218-3BF88B95-5B26-4858-9DE2-95CB1CCBF6EAQ28368663-4A015A28-262A-407A-B026-858A2926832DQ28369155-5637AF0E-18E4-49FA-90A1-74BF50DE0393Q28378617-81EAC004-4768-4C8D-9A69-2E00C89E7C2BQ28378749-FD1A17CB-69AF-4CA4-80DA-18C993C51B62Q28379176-6C33DEAC-6EDB-457C-AB9E-EBDE56E5077BQ33690206-AB221B83-5775-429B-B7CB-1892FC760F6BQ33760023-26CBFF0E-DA06-4D16-AD3D-F5C0C84E13C0Q34004458-CD1DCF4A-8817-4EAF-8A20-D30A3B38E18AQ34146531-A46A89F1-5DD5-4033-BC58-FFD07F1C45F2Q34522402-5950C256-B3F4-4F6E-9676-BEBACCAFC1CAQ35100687-841FAFF3-15C2-49C7-AC7F-3266E8A6ACF7Q35104130-21C1825F-60FD-4E48-AA6C-9D17D5DB0A29Q35130708-EF268A9A-D651-456C-86AB-EEE8BE441D91Q35370226-BCC17972-469D-412C-AB53-E794394EF23EQ35384996-B29C7915-59BF-47B2-AAC8-14E254FA72E1Q35464509-2006C0F0-BE11-4BB9-8EA0-EF93D240812FQ35533177-10AE2CE8-072F-42CC-825B-246245503924Q35548643-7569BF98-22A4-4F6E-91B5-6DAC26B2D44EQ35675914-823C653C-F43E-4AA0-A0B1-47C052478A17Q35774008-6B3D98ED-4012-4E80-AB6E-4E79E9E49370Q35990358-F027FEF5-407C-4E40-9CE0-4FCAD3C2BA2DQ36473342-67C4619C-E857-43AE-BFB1-FA48E29F6665Q36635540-DB7E5694-A3B6-429C-89EC-CEF171121F27Q36640345-80ED6308-FA54-461E-B761-B1324B8A9D45
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Mycobacterium avium complex infection.
@en
Mycobacterium avium complex infection.
@nl
type
label
Mycobacterium avium complex infection.
@en
Mycobacterium avium complex infection.
@nl
prefLabel
Mycobacterium avium complex infection.
@en
Mycobacterium avium complex infection.
@nl
P356
P1476
Mycobacterium avium complex infection.
@en
P2093
P304
P356
10.1093/INFDIS/157.5.863
P407
P577
1988-05-01T00:00:00Z